Labetalol Hydrochloride
- Product NDC
- 72266-102
- Requested package NDC
- 72266-102-01
- 11-digit product format
- 722660102
- Labeler code
- 72266
- Product ID
- 72266-102_189abc58-65af-e772-e063-6394a90a5ed3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Fosun Pharma USA Inc.
- Application
- ANDA090699
- Marketing category
- ANDA
- Marketing start
- 2019-04-02
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090699-001 | LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090699-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A090699-001 | LABETALOL HYDROCHLORIDE | 5MG/ML | INJECTABLE / INJECTION | AP | 2012-04-03 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A090699-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A090699-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A090699-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090699-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090699-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090699-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090699-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090699-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090699-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A090699-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A090699-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A090699-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A090699-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A090699-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A090699-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A090699-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A090699-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A090699-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A090699-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A090699-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A090699-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A090699-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A090699-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A090699-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A090699-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A090699-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A090699-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A090699-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A090699-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A090699-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A090699-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A090699-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A090699-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A090699-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A090699-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A090699-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A090699-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A090699-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A090699-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A090699-001 | AP | 1 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Labetalol Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LABETALOL HYDROCHLORIDE | 5 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1GEV3BAW9J | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 896771 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4a5ffab2-a3b8-411e-992d-7f38d508643a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cb89b86a-369e-4204-8910-ae797c503af3 | Product name | 1 | 20230706 |
| baf61d8c-dcd3-e95d-db84-9bb0d0a2b77f | Product name | 2 | 20220311 |
| 759f1c41-9262-4238-8cee-33988631aaf4 | Product name | 5 | 20220217 |
| 3b2edbb4-6acf-4674-b1d9-22addd3dad21 | Product name | 1 | 20210527 |
| d4880ace-a516-8c47-8dfd-73a4ba5887d7 | Product name | 2 | 20180830 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72266-102-01 | Labetalol Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 72266-102-01 | Labetalol Hydrochloride | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION | 20 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72266-102-01 | ML - Milliliter | 72266-102 | 99daf771-9c36-4b9e-9c20-81ec96baaee4 | 1 | 2019-08-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Mullan Pharmaceutical Inc. | fb5ef3ba-0a7e-4f41-9547-d734983da0d3 | 2025-12-01 | Warnings, Adverse reactions | 090699 ANDA090699 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Gland Pharma Limited | 48caf986-3126-48e1-afcd-16d65c9cfe00 | 2024-05-21 | Warnings, Adverse reactions | 090699 ANDA090699 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Fosun Pharma USA Inc. | 4a5ffab2-a3b8-411e-992d-7f38d508643a | 2024-05-16 | Warnings, Adverse reactions | 090699 ANDA090699 72266-102-01 72266-102 72266010201 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Fosun Pharma USA Inc. | f18dff28-f6f5-4ecb-9797-25062e247559 | 2021-01-28 | Warnings, Adverse reactions | 090699 ANDA090699 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 896771 | labetalol HCl 5 MG/ML Injectable Solution | PSN | 4a5ffab2-a3b8-411e-992d-7f38d508643a | 4 |
| 896771 | labetalol hydrochloride 5 MG/ML Injectable Solution | SCD | 4a5ffab2-a3b8-411e-992d-7f38d508643a | 4 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72266-102-01 | 72266010201 | 1 VIAL, MULTI-DOSE in 1 CARTON (72266-102-01) / 20 mL in 1 VIAL, MULTI-DOSE | 2019-04-02 | 0000-00-00 | No | No | Current |